L. Farber

发表

High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.

J. Bertino, C. Portlock, D. Fischer, 1987, Cancer treatment reports.

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.

D. Zelterman, K. Roberts, E. Salloum, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mediastinal irradiation in combined modality therapy for Hodgkin's disease.

R. Peschel, C. Portlock, L. Farber, 1990, International journal of radiation oncology, biology, physics.

Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer

S. Ariyan, M. Sznol, H. Kluger, 2008, Journal of immunotherapy.

Primary large cell lymphomas of the mediastinum: an analysis of 20 cases.

E. J. Dohring, L. Farber, J. Waldron, 1985, Seminars in diagnostic pathology.

Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.

P. Hoffer, L. Farber, D. Cooper, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.

J. Bertino, J. Bertino, L. Prosnitz, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second solid malignancies after combined modality therapy for Hodgkin's disease.

L. Prosnitz, L. Farber, D. Cooper, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma for the nononcologist.

W. Hait, E. Cadman, L. Farber, 1985, JAMA.

Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.

J. Bertino, D. Berd, E. Cadman, 1977, Cancer treatment reports.

High‐dose pulse chlorambucil. Effective therapy for rapid remission induction in nodular lymphocytic poorly differentiated lymphoma

F. Drislane, J. Bertino, L. Prosnitz, 1982, Cancer.

Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.

J. Bertino, L. Prosnitz, L. Farber, 1973, Radiology.

Supradiaphragmatic Hodgkin's disease: significance of large mediastinal masses.

L. Prosnitz, L. Farber, A. Knowlton, 1980, International journal of radiation oncology, biology, physics.

Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy

L. Prosnitz, G. Friedlaender, L. Farber, 1981, Cancer.

Combined modality therapy for advanced Hodgkin's disease: long-term followup data.

J. Bertino, L. Prosnitz, D. Kapp, 1982, Cancer treatment reports.

Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience.

J. Bertino, L. Prosnitz, D. Fischer, 1986, Journal of Clinical Oncology.

Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.

D. S. Fischer, S. Ariyan, C. Ariyan, 2004, Journal of the American College of Surgeons.

Long term remissions with combined modality therapy for advanced Hodgkin's disease

J. Bertino, L. Prosnitz, D. Fischer, 1976, Cancer.

Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.

J. Bertino, L. Prosnitz, D. Fischer, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease.

J. Bertino, E. Cadman, L. Farber, 1986, Blood.

Prognostic indicators in diffuse large-cell (histiocytic) lymphoma.

J. Bertino, C. Portlock, L. Farber, 1986, International journal of radiation oncology, biology, physics.

Curative potential of combined modality therapy for advanced Hodgkin's disease

J. Bertino, L. Prosnitz, D. Fischer, 1980, Cancer.

Treatment selection for stage IIIA Hodgkin's disease patients.

L. Prosnitz, D. Kapp, E. Cox, 1984, International journal of radiation oncology, biology, physics.

The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.

J. Bertino, J R Bertino, J. Marsh, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved therapeutic index of methotrexate with "leucovorin rescue".

J. Bertino, R. Deconti, E. Thomas, 1973, Cancer research.

Pseudohyperparathyroidism in head and neck tumors

S. Ariyan, L. Farber, B. Hamilton, 1974, Cancer.

Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy

L. Prosnitz, G. Friedlaender, L. Farber, 1980, Cancer.

A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.

J. Bertino, D. Fischer, E. Cadman, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.

M. Nerenberg, J. Bertino, L. Newcomer, 1982, Cancer treatment reports.

The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy

J. Bertino, L. Prosnitz, D. Fischer, 1983, American journal of clinical oncology.

Bone involvement in Hodgkin's disease

J. Bertino, L. Prosnitz, E. Cadman, 1982, Cancer.

Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer

M. Reiss, D. Zelterman, G. Chung, 2005, Oncology.

Stage I and II subdiaphragmatic Hodgkin's disease

R. Peschel, C. Portlock, L. Farber, 1991, Cancer.

Combination sequential chemotherapy in advanced reticulum cell sarcoma

J. Bertino, R. Deconti, J. Marsh, 1972, Cancer.

The usefulness of the lukes‐collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapy

M. Nerenberg, J. Bertino, L. Newcomer, 1982, Cancer.

Multiple myeloma presenting as a pituitary tumor.

L. Harrison, F. Cardinale, L. Farber, 1987, International journal of radiation oncology, biology, physics.

Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer

S. Ariyan, M. Sznol, H. Kluger, 2008, Journal of immunotherapy.